Endovascular therapy of TASC-D lesion in critical limb ischemia
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Abstract
Critical limb ischemia (CLI) is a terminal stage of peripheral artery disease (PAD); it is
defined by the presence of resting pain and/or tissue loss for at least two weeks that may
require urgent revascularization to promote healing and prevent limb loss. For patients with
infrarenal aortoiliac occlusive disease, the revascularization options are surgery like
aortofemoral bypass and axillofemoral bypass or percutaneous intervention. Aortoiliac and
aortofemoral bypass procedures are associated with 74% to 95% 5-year patency rates,
respectively, which are comparable but not superior to percutaneous therapies. These
operations may imply a significant morbidity and mortality on CLI patients who usually have
multiple comorbid conditions and are considered high risk patients.
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Case description and method
Our patient is a 52-year-old smoker female patient with past medical history of hypertension,
hyperlipidemia and severe PAD with totally occluded infrarenal abdominal aorta just distal to
the renal arteries, and known right axillofemoral bypass and fem-fem bypass. She presented
with bilateral leg and foot pain at rest, diminished pulses and ulceration of the legs
(Rutherford class VI). ABIs were obtained and were abnormal (right leg: ABI: 0.27, TBI:0.
12. Left leg: ABI:0. 3, TBI: 0.12). CT angiography showed total occlusion of the axillo-femfem bypass, totaled infra-renal aorta with reconstitution of peripheral circulation at the level
of external iliac arteries bilaterally. These findings were confirmed by angiogram obtained by
accessing right radial artery, as shown in figures 1, 2 and 3.

Figure 1: Angiogram of the right axillary artery showing occluded axillo-femoral bypass.

Figure 2: Aortogram showing occluded infrarenal aortic artery.

Figure 3: Angiogram right lower extremity showing reconstitution at the level right iliac artery
bifurcation. Right external artery and common femoral artery are diffusely disease with multi focal
stenosis.

Using the radial access in conjunction with ultrasound guided access to the right and left
femoral arteries respectively, successful PTA and stents to the abdominal aorta using self
expandable stent, also to the right and left common iliac arteries using covered stents in a
kissing fashion as well as treatment of the right and left external iliac arteries were
successfully obtained, as shown in figures 4, 5, 6, 7, 8 and 9. After three weeks follow up, the
patient’s symptoms resolved, and she had good pulses bilaterally with healing ulcers and
favorable ABIs (Right leg: ABI: 0.84, TBI: 0.68, Left leg: ABI: 0.82, TBI: 0.65).

Figure 4: Balloon angioplasty of the distal abdominal aorta and right common iliac artery.

Figure 5: Balloon angioplasty of the iliac arteries extending to the aorta.

Figure 6: Stenting of the abdominal aorta using a self-expandable stent.

Figure 7: Stenting of the right and left iliac artery in a kissing fashion.

Figure 8: Angiogram image showing the abdominal aorta, right and left iliac stents after deployment.

Figure 9: Angiogram image of the left lower extremity showing restoration of flow in the distal aorta
bilateral common iliac, left external iliac, left common femoral to the level of left superficial femoral
artery.

Discussion
CLI (Rutherford class IV-VI) is a terminal stage of peripheral artery disease (PAD); it is
defined by the presence of resting pain and/or tissue loss for at least 2 weeks.1 The target of
therapy of CLI is to restore pulsatile flow to the distal limb with as low procedural morbidity
as possible.
The Trans-Atlantic Inter-Society Consensus (TASC) document describes characteristic lesion
morphology for ideal (type A) and unfavorable (type D) iliac lesions for endovascular
therapy.4 The Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial was a
British multicenter randomized trial that compared an initial strategy of angioplasty with
open surgery in 452 patients with CLI. Overall, this trial showed that there was no significant
difference in amputation-free survival (AFS) or overall survival (OS) between the two
strategies. However, for those patients who survived for at least 2 years after randomization,
a bypass surgery (BSX)-first revascularization strategy was associated with a significant
increase in subsequent OS and a trend towards improved AFS compared to balloon
angioplasty (BAP)-first revascularization strategies.5
With advancement of technology and refinement of technical skills, endovascular therapy
might be an option on a case-by-case basis. For patients with infrarenal aortoiliac occlusive
disease, the revascularization options are surgery like aortofemoral bypass and axillofemoral
bypass or percutaneous intervention. Aortoiliac and aortofemoral bypass procedures are
associated with 74% to 95% 5-year patency rates, respectively, which are comparable but not
superior to percutaneous therapies.2,3 Because many of these operations involve extensive
abdominal incision, many of these operations may imply a significant morbidity and
mortality on CLI patients who usually have multiple comorbid conditions and are considered
high risk patients.
Endovascular treatment of aortoiliac occlusive disease has high technical success rates of 82–
98%, even in the setting of aortic occlusion.6,7 Due to the availability and advancement of
endovascular stents, the number of aortoiliac lesions that may be treated percutaneously has
been increased significantly. For common iliac bifurcation lesions, kissing balloon–
expandable stents have become the preferred option. In small several series involving
aortoiliac intervention, there was high success of stent placement, no major complications,
symptomatic improvement, and 2-year patency rate approaching 87%.2 Endovascular
treatment options include angioplasty and stenting; stenting has been shown to have higher
patency and technical success than angioplasty, without increased complications.6,8
In our case we used a self-expanding nitinol stent, which we recommend to use in these
situations because they are widely used, require a smaller sheath size (6-7 Fr.), are simply
deployed, and are less likely to interfere with the renal arteries flow after deployment.
Ideally, assessment of the intraluminal diameter with IVUS is recommended, as the selfexpanding nitinol stents have limited sizes up to 14mm. In our case, we elected to proceed
directly with 14 mm self expandable stent based on the fact that the size of the distal aorta in
women above the age of 50 is 14.6 +/- 1.9 mm,9 which seemed to be reasonable to use.
On the other hand a stent graft could be a valuable option for larger aortic diameter despite
little evidence to support their use. There are several reports using stent grafts especially in
active thrombosis. In atherosclerotic aortic disease, stent grafts do not increase the patency
rates and theoretically increase the risk for ‘toothpasting’ possibly leading to embolization of

plaque and thrombus.6,10 Plaque embolization and migration might occur proximally and
distally. Furthermore, in this case the chances of renal arteries occlusion might be higher
given the nature of occlusion as illustrated in the angiogram. Endovascular treatment for
infrarenal aortic disease can be performed with lower morbidity than with open surgery and
with better durability than extra-anatomic bypass; however, there are no randomized
controlled trial data to compare.
Conclusion
Endovascular treatment of infrarenal aortoiliac occlusive disease can be performed with
lower morbidity than aortofemoral bypass and with better durability than axillofemoral
bypass. Patients with TASC D lesions generally will be considered surgical candidates, but
with the advancement of technology and availability of several endovascular stents,
endovascular therapy might be an option on a case-by-case basis.
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